Shuya Han
Overview
Explore the profile of Shuya Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z, et al.
Mol Cancer
. 2025 Mar;
24(1):61.
PMID: 40025508
Aberrant lipid metabolism is a well-recognized hallmark of cancer. Notably, breast cancer (BC) arises from a lipid-rich microenvironment and depends significantly on lipid metabolic reprogramming to fulfill its developmental requirements....
2.
Hao X, Han S, Qin D, Zhang Y, Jin P, Du Q
RSC Adv
. 2022 Apr;
11(8):4646-4653.
PMID: 35424385
The aim of this study was to improve the stability of eugenol-casein nanoparticles (EL-CS-NPs) through polyethylene glycol (PEG) modification. The results show that modifying the EL-CS-NPs with PEG after loading...
3.
Zhang Y, Han S, Wang Y, Zhang H, Yu C, Qin D, et al.
Food Funct
. 2022 Jan;
13(3):1291-1298.
PMID: 35028655
(-)-Epigallocatechin gallate (EGCG)-incorporated casein nanoparticles benefit from excellent antioxidant, anti-inflammatory and anti-cancer activities due to their synergistic efficiency, but few studies have evaluated their safety. In this study, the EGCG-casein...
4.
Dwivedi P, Kiran S, Han S, Dwivedi M, Khatik R, Fan R, et al.
ACS Appl Mater Interfaces
. 2020 May;
12(21):23737-23751.
PMID: 32374147
Effective delivery of chemotherapeutics with minimal toxicity and maximal outcome is clinically important but technically challenging. Here, we synthesize a complex of doxorubicin (DOX)-loaded magneto-liposome (DOX-ML) microbubbles (DOX-ML-MBs) for magnetically...
5.
Zhu Z, Wu Q, Li G, Han S, Si T, Xu R
J Mater Chem B
. 2020 Apr;
4(15):2723-2730.
PMID: 32263297
A droplet-based microfluidic flow-focusing system was developed for on-chip fabrication of stimuli-responsive microdroplets (SRMs) that underwent rapid liquid-to-gas phase transition and volume expansion upon external stimuli. Silver nanoparticles (SNPs) were...
6.
Dwivedi P, Han S, Mangrio F, Fan R, Dwivedi M, Zhu Z, et al.
Mater Sci Eng C Mater Biol Appl
. 2020 Jan;
108:110326.
PMID: 31924044
No abstract available.
7.
Dwivedi P, Han S, Mangrio F, Fan R, Dwivedi M, Zhu Z, et al.
Mater Sci Eng C Mater Biol Appl
. 2019 Jun;
102:113-123.
PMID: 31146981
Ovarian cancer is one of the most lethal gynecologic malignancies due to its rapid proliferation, frequent acquisition of chemoresistance, and widespread metastasis within the peritoneal cavity. Intraperitoneal (IP) chemotherapy has...
8.
Han S, Dwivedi P, Mangrio F, Dwivedi M, Khatik R, Cohn D, et al.
Artif Cells Nanomed Biotechnol
. 2019 Mar;
47(1):957-967.
PMID: 30892967
The current clinical paradigm for ovarian cancer treatment has a poor prognosis, partially due to the efficacy and toxicity concerns associated with the available chemotherapeutic formulations. To overcome these limitations,...
9.
Dwivedi P, Yuan S, Han S, Mangrio F, Zhu Z, Lei F, et al.
Artif Cells Nanomed Biotechnol
. 2018 Oct;
46(sup3):S481-S491.
PMID: 30299174
In our study, we have established a novel liquid-driven co-flow focusing (LDCF) process to fabricate curcumin (CUR)-loaded poly (lactic-co-glycolic acid) (PLGA) microparticles (CPMs). LDCF-CPMs of size 20.26 ± 2.37 μm...
10.
Mangrio F, Dwivedi P, Han S, Zhao G, Gao D, Si T, et al.
Mol Pharm
. 2017 Nov;
14(12):4725-4733.
PMID: 29096443
Artemether is one of the most effective drugs for the treatment of chloroquine-resistant and Plasmodium falciparum strains of malaria. However, its therapeutic potency is hindered by its poor bioavailability. To...